NCT04887662

Brief Summary

The purpose of this project is to determine whether regular consumption of fermented vegetables can decrease inflammation and change the types of bacteria that are normally present in the large intestine. Recent research studies have linked the gut bacteria to many disorders and conditions, such as obesity, cardiovascular disease, diabetes, etc. We also know that certain bacteria are considered probiotic bacteria because they contribute to a healthy gut, while others have been associated with inflammation and disease. Fermented foods may contain beneficial bacteria that may improve health in humans. However, there is a lack of research studies examining the effects of regular consumption of fermented foods on health. This study will help investigators better understand if regular consumption of fermented vegetables can improve inflammation and change the gut bacteria towards a more beneficial profile.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
87

participants targeted

Target at P25-P50 for not_applicable cardiovascular-diseases

Timeline
Completed

Started May 2021

Shorter than P25 for not_applicable cardiovascular-diseases

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 4, 2021

Completed
1 day until next milestone

Study Start

First participant enrolled

May 5, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 14, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 6, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 6, 2021

Completed
Last Updated

January 22, 2024

Status Verified

January 1, 2024

Enrollment Period

7 months

First QC Date

May 4, 2021

Last Update Submit

January 18, 2024

Conditions

Keywords

C-reactive proteinlipopolysaccharide binding proteintrimethylamine oxideOxidized LDL receptor

Outcome Measures

Primary Outcomes (5)

  • Change in C-reactive protein

    ng/mL

    baseline and 8 weeks later

  • Change in oxidized LDL receptor

    pg/mL

    baseline and 8 weeks later

  • Change in trimethylamine oxide

    ng/mL

    baseline and 8 weeks later

  • Change in lipopolysaccharide binding protein

    ng/mL

    baseline and 8 weeks later

  • Change in Shannon Index

    no unit

    baseline and 8 weeks later

Secondary Outcomes (1)

  • Change in angiopoietin-like protein 4

    baseline and 8 weeks later

Study Arms (2)

Control

NO INTERVENTION

The control group will be asked to follow their usual diet, but will receive print materials about a diet for cardiovascular health.

Fermented vegetable

EXPERIMENTAL

The fermented vegetable group will be asked to consume 100 g of fermented vegetables per day, at least 5 days per week for 8 weeks.

Other: Fermented vegetable

Interventions

Participants will be asked to consume 100 g of fermented vegetables per day, at least 5 days per week, for 8 weeks

Fermented vegetable

Eligibility Criteria

Age35 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • BMI over 25.9
  • Generally healthy

You may not qualify if:

  • Diabetes
  • Taking statins
  • Taking monoamine oxidase inhibitors
  • Salt sensitivity
  • Uncontrolled hypertension
  • Diagnosed with Autoimmune disease
  • Regular use of probiotics
  • Regular use of antibiotics
  • Pregnant or breastfeeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of North Florida

Jacksonville, Florida, 32224, United States

Location

Related Links

MeSH Terms

Conditions

Cardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2021

First Posted

May 14, 2021

Study Start

May 5, 2021

Primary Completion

December 6, 2021

Study Completion

December 6, 2021

Last Updated

January 22, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations